The effect of chloroquine and hydroxychloroquine on neutrophil superoxide release stimulated by the chemotactic tripeptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) was examined. Both drugs caused time and dose dependent inhibition of superoxide release but had no effect on equilibrium binding of [3H]FMLP to its receptor. Preliminary experiments suggest that these drugs may exert their inhibitory effect on superoxide release by inhibiting the FMLP stimulated hydrolysis of phosphoinositides.
Both these cell types are intimately involved in the pathogenesis of inflammatory arthritis.
Inhibitory effects of these drugs on phagocyte function have been attributed to their lysosomotropism, which results in inhibition of lysosomal functions, including lysosomal enzyme release, receptor recycling, lysosomal digestion, and metabolism of lipids.1 They also inhibit non-lysosomal functions, including cytokine release2 and chemotaxis. 3 We have recently reported that these drugs have differential effects on other non-lysosomal aspects of blood monocyte metabolism and function, including superoxide production, phospholipid methylation, and arachidonic acid (AA) release. 4 We have extended these studies to examine the effect of CQ and HCQ on PMN superoxide release stimulated by the chemotactic tripeptide, N-formyl-methionylleucyl-phenylalanine (FMLP).
We report here that these agents inhibit FMLP stimulated superoxide release without affecting Accepted for publication 12 April 1987. Correspondence to Dr N P Hurst included in the medium, however, the effect of CQ became clearly time dependent (Fig. 2) .
Kinetic studies showed that CQ and HCQ inhibited both the initial rate and total superoxide production stimulated by FMLP (Fig. 3) .
Neither drug affected unstimulated basal PMN 
